Do weight loss injections actually work — and what does the evidence say?

The biggest misconception: that the results are too good to be true

Scepticism about weight loss injections is understandable. For decades, weight-loss products have over-promised and under-delivered, so when clinical trials report 20% average body-weight reduction, it sounds like marketing copy. It is not. The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised 2,539 adults with obesity over 72 weeks and found that participants taking tirzepatide 15mg lost an average of around 20–21% of their body weight. For someone weighing 110kg, that is 22kg or more. These are not fringe results from a small study.

The reason the figures hold up is that the medicines work on biology that has nothing to do with motivation. GLP-1 receptor agonists mimic a gut hormone released after eating, they tell the brain the stomach is full, slow down how quickly food leaves the stomach, and reduce appetite between meals. Tirzepatide also activates GIP receptors, a second gut-hormone pathway; it is the only dual-acting medicine of this type licensed in the UK. The NHS tirzepatide page covers how this mechanism works at a patient level. If you want a detailed look at the mechanism behind these medicines, our page on how the weight loss injection works goes into the biology more fully.

So no, the results are not too good to be true. They are peer-reviewed, regulator-assessed, and the basis on which NICE recommended both medicines for eligible adults in the UK.

What the injections actually do, and what they do not do

A question our prescribers hear regularly is whether the injection does the work so you do not have to. The honest answer is that it changes the conditions under which you make decisions about food, it does not make those decisions for you. People on treatment typically feel fuller on less food, experience fewer hunger cravings between meals, and find that the pull towards high-calorie foods weakens. That is real and physiological, not imaginary.

What the injection does not do is override a diet that provides far more energy than the body needs, compensate for no physical activity, or produce results indefinitely if treatment stops. Trial data consistently show that a significant proportion of the weight lost returns after discontinuation if eating habits have not changed. The most effective outcomes come when the medicine is part of a broader approach, one that includes nutritional changes and movement, reviewed regularly by a clinician.

Understanding how quickly results tend to appear is a common follow-up question, and if you are wondering how fast weight loss injections work, our dedicated page sets out what the evidence says about the pace of change week by week. Many people also want to know how long weight loss injections take to work, and our page on that topic walks through what realistic timelines look like based on the clinical evidence. And for a broader overview of the treatment options themselves, our weight loss injections page covers what is licensed and available.

Side effects: real, manageable, and worth knowing about

Knowing that the medicines work does not mean ignoring what comes with them. The most common side effects are gastrointestinal: nausea, loose stools, constipation, indigestion, and occasionally vomiting. These tend to be most noticeable in the first weeks after starting or after a dose increase, and most people find they settle. Starting at the lowest dose and titrating slowly (which is how the licensed schedule is designed) is what reduces this burden.

Less common but more serious effects include acute pancreatitis. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines flagging acute pancreatitis as an infrequent but potentially serious risk: severe, persistent stomach pain that may spread to the back, with or without vomiting, warrants urgent medical attention. You can report any suspected side effects via the MHRA Yellow Card scheme.

Pregnancy, breastfeeding, and planning to conceive are situations where these medicines are not recommended. People under 18 are not within the licensed population. For anyone on oral contraceptives starting tirzepatide, adding a non-oral method of contraception for the first four weeks of treatment (and four weeks after each dose increase) is advised, because the pill's absorption may be reduced during that period.

Keeping your pen stored correctly matters too, it lives in the fridge between doses (2–8°C), and the exact room-temperature window for each product is set out in the Patient Information Leaflet, which your prescriber will direct you to.

Who is eligible, and how private treatment works

The licensed criteria for private treatment are: adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related health condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. Lower BMI thresholds can apply for some ethnic backgrounds under UK clinical guidance. BMI alone is not the whole picture; a prescriber weighs your full health history before approving treatment.

NHS access exists but is phased and criteria-dependent, NICE recommended tirzepatide in December 2024 (TA1026), but NHS eligibility currently requires higher BMI thresholds and multiple qualifying conditions. Many people turn to a regulated private pharmacy rather than wait, and if you are based in Nevada, our page on weight loss injections in Reno outlines the local options available through our service. If you are weighing up where to access treatment, our page on where to buy weight loss injections explains what to look for in a legitimate provider, including how to verify any pharmacy on the GPhC register.

For an overview of what treatment with a clinician-led service involves from first consultation to delivery, our weight loss overview is a good place to start. When you are ready to take the next step, you can check your eligibility with our prescribers through a free consultation, reviewed the same day by a real clinician, not an automated system.